Position in ERAS
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$29,910,024
+$29,275,650 QoQ
Shares Held
1,848,580
+984.0% QoQ
Ownership
0.594%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ERAS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS Group AG holds $8,306,928,575 across 560 Biotechnology names. ERAS ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
22,619,472 | $626,559,372 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
5,177,796 | $545,739,697 | |
| 3 | ABVX |
Abivax S.A.
|
4,547,406 | $506,353,656 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
4,386,791 | $426,615,424 | |
| 5 | INSM |
INSMED Inc
|
1,737,481 | $284,112,890 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
630,618 | $281,596,158 | |
| 7 | APLS |
Apellis Pharmaceuticals, Inc.
|
6,206,681 | $249,694,775 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
299,979 | $231,775,770 |
All Filings in ERAS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,910,024 | 1,848,580 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $634,374 | 170,531 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $318,630 | 146,161 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $629,471 | 495,647 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $189,653 | 138,433 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $484,851 | 193,168 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $629,598 | 230,622 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $106,497 | 45,126 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $163,813 | 79,521 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $238,229 | 111,845 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $107,742 | 54,692 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $151,297 | 54,818 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $94,106 | 31,265 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $850,444 | 197,319 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $22,424 | 2,875 | Shares | Defined | 2022-11-10 | |
| 2021-12-31 | $117,301 | 7,529 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $15,384 | 725 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||